EUVIMEDEUVIMED entdecken
Crossref

Association of Matrix Metalloproteinase-2 (MMP-2) and MMP-9 Promoter Variants, Their Serum Levels, and Activities with Aortic Valve Calcification (AVC) in a Population from Western Iran

Reza Heidari Moghadam, Fatemeh Babajani, Afshin Karami, Daniel Elieh-Ali-Komi iD, Faeghe Hoseini, Nahid Salehi, Saeed Elahirad, Ehsan Mohammadi-Noori, Hossein Mohammadi, Amir Kiani

Genetic Testing and Molecular Biomarkers · 2024

DOI: 10.1089/gtmb.2023.0370 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genetic Testing and Molecular Biomarkers, 2024. Verfasst von Reza Heidari Moghadam und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran. Hauptthemen laut MEDLINE: Matrix Metalloproteinase 9, Calcinosis, Matrix Metalloproteinase 2, Aortic Valve. Die Arbeit nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Matrix metalloproteinase (MMP) enzyme gene polymorphisms MMP-2-1575G/A and MMP-9-1562C/T promoter polymorphism, their serum levels, and activity are associated with aortic valve calcification (AVC). Materials and Methods: The synergistic link between the risk of AVC and the alleles T and A of MMP-9 and MMP-2 was investigated, respectively. Ninety-two cases with AVC and 92 healthy individuals from the west of Iran were included, and MMP- 2-1575G/A and MMP-9-1562C/T promoter polymorphisms were detected using PCR-RFLP. The serum levels and activity of MMP-2 and -9 were assessed using ELISA and gelatin zymography methods, respectively. In addition, serum biochemical markers, including FBS, urea and creatinine, cholesterol, triglyceride, HDL, LDL, calcium, phosphorus, and blood pressure: systolic blood pressure and diastolic blood pressure were measured.

Results

Heart valve calcification disease was associated with a comparatively higher frequency of the A allele of the MMP2-1575 variation (p = 0.002). In addition, the frequency of T allele of the MMP9-1562 variant was higher than the control group (p = 0.007).

Conclusion

MMP-2 and MMP-9 serum levels and activities were observed to be considerably higher in the experimental group than in the control group (p < 0.001). Patients are more susceptible to cardiovascular disease than the control group due to elevated serum levels and activity of MMP-2 and MMP-9.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Matrix Metalloproteinase 9CalcinosisMatrix Metalloproteinase 2Aortic ValvePromoter Regions, GeneticAortic Valve StenosisGenetic Predisposition to DiseaseHumansFemaleMaleIranMiddle AgedPolymorphism, Single NucleotideAgedAdultAllelesCase-Control StudiesGene FrequencyHeart Valve DiseasesGenotype

Stichwörter der Autor:innen

MMP-2MMP-2-1575G/A SNPMMP-9MMP-9-1562 C/T SNPaortic and mitral valve calcification

Substanzen

Matrix Metalloproteinase 9Matrix Metalloproteinase 2MMP9 protein, humanMMP2 protein, human

Autor:innen und Institutionen

  • Cardiovascular Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Students Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Regenerative Medicine Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Institute of Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.
  • Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.

ORCID-Profile: Daniel Elieh-Ali-Komi

Zitieren

APA

Heidari Moghadam, R., Babajani, F., Karami, A., Elieh-Ali-Komi, D., Hoseini, F., Salehi, N., Elahirad, S., Mohammadi-Noori, E., Mohammadi, H., & Kiani, A. (2024). Association of Matrix Metalloproteinase-2 (MMP-2) and MMP-9 Promoter Variants, Their Serum Levels, and Activities with Aortic Valve Calcification (AVC) in a Population from Western Iran. Genetic Testing and Molecular Biomarkers. https://doi.org/10.1089/gtmb.2023.0370

Vancouver

Heidari Moghadam R, Babajani F, Karami A, Elieh-Ali-Komi D, Hoseini F, Salehi N, et al. Association of Matrix Metalloproteinase-2 (MMP-2) and MMP-9 Promoter Variants, Their Serum Levels, and Activities with Aortic Valve Calcification (AVC) in a Population from Western Iran. Genetic Testing and Molecular Biomarkers. 2024. doi:10.1089/gtmb.2023.0370

BibTeX
@article{HeidariMoghadam2024,
  author = {Heidari Moghadam, Reza and Babajani, Fatemeh and Karami, Afshin and Elieh-Ali-Komi, Daniel and Hoseini, Faeghe and Salehi, Nahid and Elahirad, Saeed and Mohammadi-Noori, Ehsan and Mohammadi, Hossein and Kiani, Amir},
  title = {Association of Matrix Metalloproteinase-2 (MMP-2) and MMP-9 Promoter Variants, Their Serum Levels, and Activities with Aortic Valve Calcification (AVC) in a Population from Western Iran},
  journal = {Genetic Testing and Molecular Biomarkers},
  year = {2024},
  doi = {10.1089/gtmb.2023.0370}
}
Kostenlos starten →